Commonly used immunosuppressives affect mesenchymal stem cell viability and function: Should we rethinking clinical trial inclusion and exclusion criteria?
Amy L. Lightner, Zeji Du, Timothy E. Peterson, Ao Shi, Mark Li, Sinibaldo Rafael Romero Arocha, Atta Behfar
Research output: Contribution to journal › Article › peer-review
Fingerprint
Dive into the research topics of 'Commonly used immunosuppressives affect mesenchymal stem cell viability and function: Should we rethinking clinical trial inclusion and exclusion criteria?'. Together they form a unique fingerprint.